U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596004) titled 'COMPARISON OF DEXMEDETOMIDINE AND NORMAL SALINE IN NEBULIZATION TO BLUNT HEMODYNAMIC RESPONS... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597733) titled 'Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy' on Nov. 17, 2... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07597499) titled 'ANCHOR Validation Trial in High-Risk Multidisciplinary Care' on May 08. Brief Summary: This... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596108) titled 'Calibre vs. COSMED' on May 05. Brief Summary: This study evaluates agreement between the Ca... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596563) titled 'Olfactory Cell Transplantation and Intensive Rehabilitation to Repair Chronic Spinal Cord In... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594899) titled 'AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL' on May 05. Brief Summary: Thi... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07595081) titled 'Propionic Acid for Multiple Sclerosis: Safety and Benefits' on May 03. Brief Summary: The p... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596251) titled 'Support Towards Addiction Recovery for Individuals With Criminal Legal System Involvement: T... Read More
U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07594756) titled 'Investigating the (Cost-)Effectiveness of an Online Social Therapy Platform (ENYOY) for Youn... Read More
Singapore, May 20 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More